Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Anemia related to hormonal ablation therapy for prostate cancer
William K. Oh
Research output
:
Contribution to journal
›
Article
›
peer-review
3
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Anemia related to hormonal ablation therapy for prostate cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Anemia
100%
Prostate Cancer
100%
Ablation Therapy
100%
Chronic Disease
20%
Monotherapy
20%
Erythropoietin
20%
Blood Transfusion
20%
Hormonal Therapy
20%
Hemoglobin Level
20%
Clinical Sequelae
20%
Relative Effect
20%
Cancer Control
20%
Anti-androgen Therapy
20%
Bilateral Orchiectomy
20%
Androgen Ablation Therapy
20%
Normocytic Anemia
20%
LHRH Agonist
20%
Medicine and Dentistry
Anemia
100%
Prostate Cancer
100%
Ablation Therapy
100%
Sequela
16%
Monotherapy
16%
Hormone Therapy
16%
Androgen
16%
Blood Transfusion
16%
Chronic Disease
16%
Gonadorelin Agonist
16%
Orchiectomy
16%
Erythropoietin
16%
Antiandrogen Therapy
16%
Cancer Control
16%
Pharmacology, Toxicology and Pharmaceutical Science
Anemia
100%
Prostate Cancer
100%
Monotherapy
16%
Androgen
16%
Chronic Disease
16%
Gonadorelin Agonist
16%
Hormone Cancer Therapy
16%
Erythropoietin
16%
Antiandrogen
16%